Found 227 clinical trials
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Currently Recruiting
Advanced and Recurrent Endometrial Cancer (DUO-E)
People with cancer are asked to participate in a research study being conducted by Icahn School of Medicine at Mount Sinai.
- 22 views
- 22 Jul, 2020
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Currently Recruiting
LEAP-001
People with endometrial carcinoma are asked to participate in a research study being conducted by Icahn School of Medicine at Mount Sinai.
- 64 views
- 02 Aug, 2019
- 1 location
-
Multi-country trial
-
Phase 1 trial
-
Accepting Seniors
-
Accepting adults
-
Currently Recruiting
A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of INCMGA00012 (formerly MGA012) in Patients with Advanced Solid Tumors
500 mg every 4 weeks in patients with endometrial cancer, specifically either microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR). Additionally, every 3 week (Q3W) flat-dosing
- 229 views
- 14 Dec, 2020
- 16 locations
-
Multi-country trial
-
Unknown Phase
-
Accepting pediatric ages
-
Accepting adults
-
Currently Recruiting
An Open-Label, Dose-Escalation, Safety Tolerability Study of INCAGN01876 in Subjects With Advanced or Metastatic Solid Tumors
An Open-Label, Dose-Escalation, Safety Tolerability Study of INCAGN01876 in Subjects With Advanced or Metastatic Solid Tumors
- 80 views
- 08 Dec, 2020
- 7 locations
-
Unknown Phase
-
Accepting pediatric ages
-
Accepting Seniors
-
1000s of participants
-
An interventional trial
-
For females only
-
Obstetrics/Gynecology (Women’s Health)
-
Currently Recruiting
Selective Targeting of Adjuvant Therapy for Endometrial Cancer (STATEC)
survival as compared to adjuvant therapy given to all women with high risk apparent stage 1 endometrial cancer.
- 33 views
- 08 Nov, 2020
-
Multi-country trial
-
Phase 4 trial
-
Accepting Seniors
-
Accepting adults
-
1000s of participants
-
An interventional trial
-
For females only
-
Obstetrics/Gynecology (Women’s Health)
-
Currently Recruiting
Biomarker Guided Treatment in Gynaecological Cancer
endometrial cancer. Predominantly, but not exclusively, such biomarkers have shown to be interesting in retrospective analysis of our large prospectively collected MoMaTEC1 series. Part 1
- 40 views
- 08 Nov, 2020
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For females only
-
Currently Recruiting
Transvaginal Ultrasound in Women With Abnormal Uterine Bleeding
The objective of this study is to investigate the role of transvaginal ultrasound in detecting endometrial hyperplasia and endometrial cancer in women aged more than 35 presenting with
- 0 views
- 08 Nov, 2020
- 1 location
-
Phase 2 trial
-
Accepting adults
-
1000s of participants
-
An interventional trial
-
For females only
-
Currently Recruiting
MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia
To compare the efficacy of Medroxyprogesterone Acetate with dydrogesterone in patients having endometrial hyperplasia (EH) without atypia.
- 0 views
- 13 Aug, 2020
- 1 location
-
Phase 2 trial
-
Accepting Seniors
-
Accepting adults
-
10s of participants
-
An interventional trial
-
For females only
-
Currently Recruiting
ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer
This is a a Simon's two-stage, non-randomized, open label, 2-arm Phase II trial of ONC201 in women with metastatic or recurrent Type II endometrial cancer who failed at least 1 prior
- 48 views
- 17 Sep, 2020
- 3 locations